|
Search -
Finance Home -
Yahoo! -
Help |
|
Quotes & Info
|
| INSM > SEC Filings for INSM > Form 8-K on 25-Jun-2009 | All Recent SEC Filings |
25-Jun-2009
Other Events, Financial Statements and Exhibits
On June 25, 2009 Insmed Incorporated published a press release announcing the results for its Phase II clinical trial of IPLEX™ in the Myotonic Muscular Dystrophy indication. A copy of the press release is attached hereto as Exhibit 99.1.
The information contained herein, including the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
(d) Exhibits
Exhibit No. Description
99.1 Press Release issued by Insmed Incorporated on June 25, 2009
|
|